The number of women who quietly carry this question — am I too late, or do I still have time? — is far larger than anyone talks about. The silence around it is its own kind of harm, because the window for making informed decisions is genuinely short and the medical system is not always set up to meet women here with nuance. This one matters.
Learn more about Rose →Cycle irregularity is one of the first signs of perimenopause, but ovulation can still occur even when periods become unpredictable or further apart. A woman in early perimenopause may still conceive spontaneously, which means contraception still matters if pregnancy is not the goal — and urgency matters if it is. Waiting for cycles to 'settle down' before acting on fertility intentions is one of the most common and costly delays women make in this window.
Anti-Müllerian hormone (AMH) is the most widely used blood marker for ovarian reserve and reflects how many eggs remain in the ovarian pool. Low AMH does not mean zero chance of conception, but it does indicate that the window is narrowing and that time-sensitive decisions — including egg freezing or IVF consultation — become more pressing. AMH can be tested at any point in the cycle and is a useful, though imperfect, starting point for a fertility conversation with a reproductive endocrinologist.
Much of the conversation around fertility over 42 focuses on 'how many eggs are left,' but egg quality — specifically chromosomal integrity — is the more clinically significant factor. The rate of aneuploidy (chromosomally abnormal eggs) rises sharply after 40, which is the primary reason miscarriage rates increase and IVF success rates with own eggs decline in this age group. This is why many fertility specialists raise the option of preimplantation genetic testing (PGT) during IVF cycles for women over 40.
Egg freezing is often discussed as a straightforward backup plan, but outcomes are strongly age-dependent and the data for women over 42 are sobering. Live birth rates per frozen egg cycle drop considerably after 40, and most reproductive medicine guidelines are transparent that the prognosis with own eggs frozen after 42 is limited. This does not mean egg freezing is never worth pursuing, but women deserve to enter that conversation with realistic numbers, not marketing language.
IVF using eggs from a younger donor largely removes the age-related egg quality problem, and success rates with donor eggs remain relatively consistent even for recipients in their mid-40s. Many women arrive at donor egg IVF after exhausting other options and wish they had known about it sooner, because starting the process earlier — including legal, psychological, and matching timelines — reduces stress and improves outcomes. Considering donor eggs is not giving up; it is accessing a genuinely effective option with a strong evidence base.
Pregnancies after 42 carry higher rates of gestational diabetes, hypertension, placenta praevia, caesarean delivery, and chromosomal conditions including Down syndrome compared to pregnancies in younger women. These risks are real and should be discussed openly with an obstetrician who specialises in high-risk or advanced maternal age pregnancies — not minimised or used as a deterrent. Many women over 42 have healthy pregnancies and healthy babies; the point is informed preparation, not discouragement.
Follicle-stimulating hormone (FSH) is sometimes used as a marker of ovarian reserve, with high FSH interpreted as a sign of declining fertility — but FSH fluctuates significantly across the cycle and even between cycles in perimenopause, making a single reading unreliable on its own. A high FSH on one test does not categorically rule out conception, and a normal FSH does not guarantee it. AMH combined with antral follicle count (AFC) via ultrasound gives a more complete picture than FSH alone.
Fatigue, nausea, breast tenderness, mood changes, and missed periods are features of both perimenopause and early pregnancy, which means women in this transition can overlook a pregnancy or mistake one for perimenopausal changes. A home pregnancy test remains accurate in perimenopause and should be used when there is any doubt. Women who are actively trying to conceive should also be aware that perimenopausal hormonal shifts can affect the interpretation of ovulation predictor kits, which rely on LH surges that may behave differently in this phase.
Women navigating fertility decisions in perimenopause are often doing so under significant time pressure, with grief for a path that feels closing, and sometimes without adequate support from partners, family, or even clinicians who may not take the question seriously. The psychological dimension of late-fertility decisions — including the grief of choosing not to pursue pregnancy, the strain of treatment, and the complexity of donor conception — is well documented and warrants dedicated support, not just a referral to 'think it over.' Seeking out a counsellor or therapist with specific experience in fertility and reproductive loss is as valid and important as any blood test.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.